BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 12-Month High – What’s Next?

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM) reached a new 52-week high on Tuesday . The company traded as high as $17.54 and last traded at $17.22, with a volume of 69520 shares trading hands. The stock had previously closed at $16.03.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised BlossomHill Therapeutics to a “hold” rating in a report on Saturday, August 15th.

BlossomHill Therapeutics Stock Performance

Insider Activity

In other news, Director Carl L. Gordon acquired 625,000 shares of the business’s stock in a transaction on Monday, August 10th. The stock was bought at an average price of $16.00 per share, with a total value of $10,000,000.00. Following the completion of the acquisition, the director owned 2,714,279 shares of the company’s stock, valued at approximately $43,428,464. This represents a 29.91% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Orbimed Advisors Llc acquired 625,000 shares of the firm’s stock in a transaction on Monday, August 10th. The stock was purchased at an average price of $16.00 per share, with a total value of $10,000,000.00. Following the transaction, the director owned 2,714,279 shares of the company’s stock, valued at approximately $43,428,464. This trade represents a 29.91% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 1,573,900 shares of company stock valued at $25,181,900 in the last three months.

BlossomHill Therapeutics Company Profile

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop small molecule medicines which address significant unmet medical needs in cancer treatment. The company’s lead clinical programs include BH-30643. BlossomHill Therapeutics Inc is headquartered in San Diego, California.